VRNA

Verona Pharma plc American Depositary Share (VRNA)

About Verona Pharma plc American Depositary Share (VRNA)

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.

Details

Daily high

$64.44

Daily low

$61.34

Price at open

$62.75

52 Week High

$70.40

52 Week Low

$11.39

Market cap

5.2B

Dividend yield

0.00%

Volume

2.3M

Avg. volume

1.6M

P/E ratio

-28.36

Verona Pharma plc American Depositary Share News